Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Angina Pectoris D000787 27 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
pmid:
Kang C et al. Preparation of Sustained Release Tablet with Minimized Usage of Glyceryl Behenate Using Post-Heating Method. 2018 AAPS PharmSciTech pmid:30094721
Fachinetti N et al. Comparative Study of Glyceryl Behenate or Polyoxyethylene 40 Stearate-Based Lipid Carriers for Trans-Resveratrol Delivery: Development, Characterization and Evaluation of the In Vitro Tyrosinase Inhibition. 2018 AAPS PharmSciTech pmid:29404955
Setthacheewakul S et al. Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). 2011 AAPS PharmSciTech pmid:21181511
Scalia S and Mezzena M Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octocrylene: effect on photostability. 2009 AAPS PharmSciTech pmid:19381836
Tran TH et al. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. 2014 AAPS PharmSciTech pmid:25035071
Bhalekar MR et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. 2009 AAPS PharmSciTech pmid:19294517
Rao M et al. Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices. 2009 AAPS PharmSciTech pmid:19333763
Abdelbary G and Fahmy RH Diazepam-loaded solid lipid nanoparticles: design and characterization. 2009 AAPS PharmSciTech pmid:19277870
Refaat A et al. A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets. 2016 Acta Pharm pmid:27749256
Mužíková J et al. Compressibility of tableting materials and properties of tablets with glyceryl behenate. 2015 Acta Pharm pmid:25781708
Gönüllü Ü et al. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. 2015 Acta Pharm pmid:25781700
Patel NV et al. Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. 2010 Acta Pharm pmid:20228040
Stanisz B et al. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase. 2010 Jan-Feb Acta Pol Pharm pmid:20210086
Kim HJ et al. Sustained-release formulation of sarpogrelate hydrochloride. 2015 Arch. Pharm. Res. pmid:24895147
Negi JS et al. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique. 2014 Arch. Pharm. Res. pmid:23695866
Jeong SH and Park K Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets. 2010 Arch. Pharm. Res. pmid:20191352
Pradhan M et al. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders. 2016 Artif Cells Nanomed Biotechnol pmid:25229831
Montana G et al. Employment of cationic solid-lipid nanoparticles as RNA carriers. 2007 Mar-Apr Bioconjug. Chem. pmid:17253655
Pivette P et al. Polymorphism of glyceryl behenates: from the individual compounds to the pharmaceutical excipient. 2014 Chem. Phys. Lipids pmid:25062895
Butani D et al. Topical Amphotericin B solid lipid nanoparticles: Design and development. 2016 Colloids Surf B Biointerfaces pmid:26700229
Vithani K et al. Sustained release solid lipid matrices processed by hot-melt extrusion (HME). 2013 Colloids Surf B Biointerfaces pmid:23759381
Moazeni M et al. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. 2016 Colloids Surf B Biointerfaces pmid:26974361
Patere SN et al. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. 2013 Curr Drug Deliv pmid:23607649
Acevedo-Morantes CY et al. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells. 2013 Drug Deliv pmid:24024505
Barakat NS et al. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. 2009 Drug Deliv pmid:19555310
Hosny KM et al. Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia. 2015 Drug Des Devel Ther pmid:25609917
McGinity M et al. Implant compositions for the unidirectional delivery of drugs to the brain. 2017 Drug Dev Ind Pharm pmid:28422529
Wong PC et al. A study on the solid state characteristics of spray-congealed glyceryl dibehenate solid lipid microparticles containing ibuprofen. 2016 Drug Dev Ind Pharm pmid:26079425
Rosiaux Y et al. Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO. 2015 Drug Dev Ind Pharm pmid:25652358
Gu X et al. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. 2004 Drug Dev Ind Pharm pmid:15595567
Iloañusi NO and Schwartz JB The effect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization. 1998 Drug Dev Ind Pharm pmid:15605595
Roberts M et al. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. 2012 Drug Dev Ind Pharm pmid:22149472
Stanisz B et al. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. 2013 Drug Dev Ind Pharm pmid:22348774
Yang R et al. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. 2011 Drug Dev Ind Pharm pmid:20578879
Punyamurthula NS et al. Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol. 2016 Drug Dev Ind Pharm pmid:26585693
Scalia S and Mezzena M Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. 2009 Drug Dev Ind Pharm pmid:18785040
Zhang YE and Schwartz JB Melt granulation and heat treatment for wax matrix-controlled drug release. 2003 Drug Dev Ind Pharm pmid:12648009
Mirghani A et al. Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate. 2000 Drug Dev Ind Pharm pmid:10872101
Faham A et al. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. 2000 Drug Dev Ind Pharm pmid:10697753
Hariharan M et al. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. 2004 Drug Dev Ind Pharm pmid:15285329
Shah M et al. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. 2011 Drug Dev Ind Pharm pmid:21128704
Hamza Yel-S and Aburahma MH Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. 2010 Drug Dev Ind Pharm pmid:19722915
UÄŸurlu T et al. Effects of lubricants on binary direct compression mixtures. 2010 Drug Discov Ther pmid:22491169
Thakkar H et al. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. 2007 Drugs R D pmid:17767393
Rahman Z et al. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. 2010 Eur J Pharm Biopharm pmid:20470882
Sznitowska M et al. The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN). 2017 Eur J Pharm Biopharm pmid:27815177
Khan S et al. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization. 2016 Eur J Pharm Biopharm pmid:27449630
Tursilli R et al. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. 2007 Eur J Pharm Biopharm pmid:17407809
Pedersen N et al. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. 2006 Eur J Pharm Biopharm pmid:16290122
Ravi PR et al. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. 2014 Eur J Pharm Biopharm pmid:24378615
Furlanetto S et al. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. 2006 Eur J Pharm Biopharm pmid:16154333
Jedinger N et al. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids. 2015 Eur J Pharm Biopharm pmid:25733499
Dudhipala N and Veerabrahma K Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. 2017 Eur J Pharm Biopharm pmid:27810472
Barthelemy P et al. Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations. 1999 Eur J Pharm Biopharm pmid:10234531
Obaidat AA and Obaidat RM Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. 2001 Eur J Pharm Biopharm pmid:11522491
Jenning V et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. 2000 Eur J Pharm Biopharm pmid:10799811
Ghimire M et al. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. 2011 Eur J Pharm Biopharm pmid:20971189
Ghimire M et al. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. 2007 Eur J Pharm Biopharm pmid:17498934
Zhang S et al. Engineering hot-melt extruded solid dispersion for controlled release of hydrophilic drugs. 2017 Eur J Pharm Sci pmid:28087352
Quintanar-Guerrero D et al. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. 2005 Eur J Pharm Sci pmid:16046105
Vaghasiya H et al. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. 2013 Eur J Pharm Sci pmid:23557842
Videira MA et al. Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics. 2013 Eur J Pharm Sci pmid:23528739
Costa A et al. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages. 2018 Eur J Pharm Sci pmid:29229273
Jannin V et al. Evaluation of the digestibility of solid lipid nanoparticles of glyceryl dibehenate produced by two techniques: Ultrasonication and spray-flash evaporation. 2018 Eur J Pharm Sci pmid:28966096
Bose S and Michniak-Kohn B Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. 2013 Eur J Pharm Sci pmid:23246734
Aji Alex MR et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. 2011 Eur J Pharm Sci pmid:20971188
Aburahma MH and Badr-Eldin SM Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. 2014 Expert Opin Drug Deliv pmid:25152197
Siram K et al. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation. 2014 Expert Opin Drug Deliv pmid:24847779
Soleimanian Y et al. Propolis wax nanostructured lipid carrier for delivery of β sitosterol: Effect of formulation variables on physicochemical properties. 2018 Food Chem pmid:29699688
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
Wang G et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. 2012 Int J Nanomedicine pmid:22275840
Lai F et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. 2007 Int J Nanomedicine pmid:18019840
Zhang H et al. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. 2012 Int J Nanomedicine pmid:22787390
Chakraborty S et al. Inhibitory effect of a new orally active cedrol-loaded nanostructured lipid carrier on compound 48/80-induced mast cell degranulation and anaphylactic shock in mice. 2017 Int J Nanomedicine pmid:28744120
Chen YC et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. 2012 Int J Nanomedicine pmid:22923986
Urbán-Morlán Z et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. 2010 Int J Nanomedicine pmid:20856836
Zhao Y et al. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation. 2017 Int J Pharm pmid:27884712
Sonawane SJ et al. Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies. 2016 Int J Pharm pmid:26992817
Makwana V et al. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. 2015 Int J Pharm pmid:26367780
Kakkar S et al. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. 2015 Int J Pharm pmid:26325312
Jeong KH et al. Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate. 2015 Int J Pharm pmid:26315121
Scoutaris N et al. SEM/EDX and confocal Raman microscopy as complementary tools for the characterization of pharmaceutical tablets. 2014 Int J Pharm pmid:24836664
Negi LM et al. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. 2014 Int J Pharm pmid:24345574
Hamdani J et al. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. 2006 Int J Pharm pmid:16824707
Li FQ et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. 2006 Int J Pharm pmid:16837152
Hamdani J et al. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. 2006 Int J Pharm pmid:16815656
Brubach JB et al. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. 2007 Int J Pharm pmid:17207945
Zhang W et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. 2013 Int J Pharm pmid:23876384
Bose S et al. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. 2013 Int J Pharm pmid:23262430
Wolska E and Sznitowska M Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM). 2013 Int J Pharm pmid:23164704
Han F et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. 2012 Int J Pharm pmid:22989987
Martínez-Acevedo L et al. Evaluation of the lubricating effect of magnesium stearate and glyceryl behenate solid lipid nanoparticles in a direct compression process. 2018 Int J Pharm pmid:29729408
Abbas H et al. Dermal anti-oxidant, anti-inflammatory and anti-aging effects of Compritol ATO-based Resveratrol colloidal carriers prepared using mixed surfactants. 2018 Int J Pharm pmid:29458209
Schöler N et al. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. 2000 Int J Pharm pmid:10699726
Blasi P et al. Lipid nanoparticles for brain targeting I. Formulation optimization. 2011 Int J Pharm pmid:21827844
N'Diaye A et al. Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. 2003 Int J Pharm pmid:12623202
Gaspar DP et al. Microencapsulated SLN: An innovative strategy for pulmonary protein delivery. 2017 Int J Pharm pmid:27864069
Gaspar DP et al. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies. 2016 Int J Pharm pmid:26656946
Kuo YC and Chen HH Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. 2009 Int J Pharm pmid:18848610